688012:SSEAdvanced Micro-Fabrication Equipment Inc. China Class A Analysis
Data as of 2026-06-12 - not real-time
CN¥316.03
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Advanced Micro-Fabrication Equipment is posting rapid revenue growth and solid profitability, with margins that comfortably exceed many peers in the semiconductor equipment sector. The stock trades well above its 20‑day, 50‑day and 200‑day moving averages, and the RSI sits in the upper‑mid range, signaling continued buying pressure, while the MACD has turned bearish and volume is trending down, hinting at a potential short‑term pullback.
Valuation is a major concern: price‑to‑earnings and price‑to‑book ratios are dramatically higher than the industry average, and a discounted cash‑flow estimate places fair value far below current levels. Dividend yield is modest and payout is low, but free cash flow is negative, raising questions about long‑term sustainability despite ample cash on hand. Overall, the company’s growth fundamentals are strong, yet the market price appears excessively stretched.
Valuation is a major concern: price‑to‑earnings and price‑to‑book ratios are dramatically higher than the industry average, and a discounted cash‑flow estimate places fair value far below current levels. Dividend yield is modest and payout is low, but free cash flow is negative, raising questions about long‑term sustainability despite ample cash on hand. Overall, the company’s growth fundamentals are strong, yet the market price appears excessively stretched.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages supports bullish bias
- MACD histogram turning negative suggests near‑term weakness
- Decreasing volume adds uncertainty to short‑term momentum
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained revenue growth and strong operating margins
- Valuation multiples remain far above peers and DCF target
- Beta low, limiting broader market volatility exposure
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Fundamental growth trajectory aligns with industry secular trends
- Persistent overvaluation may lead to correction before upside
- Modest dividend and low payout ratio provide limited income cushion
Key Metrics & Analysis
Financial Health
Revenue Growth34.10%
Profit Margin20.79%
P/E Ratio108.6
ROE12.03%
ROA3.42%
Debt/Equity3.09
P/B Ratio12.1
Op. Cash FlowCN¥1.8B
Free Cash FlowCN¥-1174535680
Industry P/E36.5
Technical Analysis
TrendBullish
RSI62.5
SupportCN¥261.60
ResistanceCN¥357.94
MA 20CN¥299.49
MA 50CN¥257.11
MA 200CN¥210.12
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Fair ValueCN¥55.21
GradeOvervalued
TypeGrowth
Dividend Yield0.12%
Risk Assessment
Beta0.23
Volatility69.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.